MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-17-2024
ThermoGenesis Holdings DPO Ratio 2011-2026 | THMO
Annual DPO Ratio ThermoGenesis Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.3 | 83.2 | 58.8 | 71.8 | 118 | 67.3 | 105 | 164 | 130 | 97.7 | 79.7 | 44.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 164 | 44.9 | 89.2 |
Quarterly DPO Ratio ThermoGenesis Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.5 | - | 27.9 | 36.5 | 54.5 | - | 61.1 | 67.8 | 83.3 | - | 58.6 | 91.9 | 152 | - | 148 | 25.6 | 75.1 | - | 61 | 56.1 | 104 | - | 90 | 135 | 136 | - | 88.7 | 96.2 | 101 | 72.2 | 85.5 | 49.9 | 135 | 203 | 199 | 205 | 153 | 90.9 | 122 | 106 | 117 | 101 | 128 | 106 | 91.2 | 46.9 | 78.2 | 89.5 | 80.8 | 51.5 | 57.6 | 53.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 205 | 25.6 | 94 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Electromed
ELMD
|
47.8 | $ 25.52 | -0.85 % | $ 216 M |  USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.97 | -5.18 % | $ 1.2 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 13.01 | -2.77 % | $ 1.76 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.22 | -0.45 % | $ 49.6 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 11.67 | -2.02 % | $ 462 M |  Curacao |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.43 | 4.57 % | $ 128 M |  France |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 178.73 | -2.26 % | $ 12.6 B | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.62 | 3.33 % | $ 38.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 10.52 | -5.05 % | $ 298 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
33.1 | $ 89.25 | -1.61 % | $ 12.1 B | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.1 | -2.33 % | $ 5.82 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
TELA Bio
TELA
|
31.8 | $ 0.77 | -0.83 % | $ 36.1 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
TransMedics Group
TMDX
|
15.5 | $ 100.9 | -0.36 % | $ 3.43 B | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 18.19 | -2.36 % | $ 1.24 B | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.92 | -4.65 % | $ 1.04 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.09 | -0.33 % | $ 354 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 10.31 | -2.27 % | $ 369 M | USA |
 |
Varex Imaging Corporation
VREX
|
42.5 | $ 11.47 | -4.97 % | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.04 | - | $ 17.6 M | USA |
 |
Vivos Therapeutics
VVOS
|
73.4 | $ 0.81 | -4.1 % | $ 8.32 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 36.03 | -2.07 % | $ 1.12 B | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 59.54 | -2.86 % | $ 3.25 B |  Britain |
 |
Inspire Medical Systems
INSP
|
103 | $ 53.69 | -2.58 % | $ 1.58 B | USA |
 |
LENSAR
LNSR
|
146 | $ 5.36 | 0.19 % | $ 64.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 84.0 | -0.76 % | $ 2.92 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |